MDX-124(Medannex)

N/A

Report date: 2023/12/08 16:00:08
First In Class

Base Information

Drug NameMDX-124(Medannex)
Drug Alias NameMDX-124
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunostimulantsAnnexin A1 inhibitors
TargetsAnnexin A1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedannex Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMedannex Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A